Collegium Pharmaceutical, Inc. (COLL)
23.53
-0.17
(-0.72%)
USD |
NASDAQ |
Sep 04, 16:00
23.52
-0.01
(-0.04%)
After-Hours: 20:00
Collegium Pharmaceutical Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 3.983M |
| December 31, 2021 | 1.609M |
| September 30, 2021 | 1.45M |
| June 30, 2021 | 3.462M |
| March 31, 2021 | 2.93M |
| December 31, 2020 | 2.472M |
| September 30, 2020 | 2.141M |
| June 30, 2020 | 2.493M |
| March 31, 2020 | 2.666M |
| December 31, 2019 | 2.398M |
| September 30, 2019 | 2.491M |
| Date | Value |
|---|---|
| June 30, 2019 | 2.459M |
| March 31, 2019 | 2.992M |
| December 31, 2018 | 2.249M |
| September 30, 2018 | 1.907M |
| June 30, 2018 | 2.237M |
| March 31, 2018 | 2.268M |
| December 31, 2017 | 2.194M |
| September 30, 2017 | 2.069M |
| June 30, 2017 | 2.179M |
| March 31, 2017 | 2.13M |
| December 31, 2016 | 3.331M |
| September 30, 2016 | 3.254M |
| June 30, 2016 | 4.301M |
| March 31, 2016 | 4.062M |
| December 31, 2015 | 1.531M |
| September 30, 2015 | 3.358M |
| June 30, 2015 | 1.641M |
| March 31, 2015 | 1.445M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Innoviva, Inc. | 5.19M |
| Zevra Therapeutics, Inc. | 4.486M |
| Supernus Pharmaceuticals, Inc. | 29.06M |
| Indivior Pharmaceuticals, Inc. | 7.00M |
| Crinetics Pharmaceuticals, Inc. | 99.38M |